Checkpoint protein inhibitor antibodies (CPI), including cytotoxic T-lymphocyte-associated antigen 4 inhibitors (ipilimumab, tremelimumab) and the programmed cell death protein 1 pathway/programmed cell death protein 1 ligand inhibitors (pembrolizumab, nivolumab, durvalumab, atezolizumab), have entered routine practice for the treatment of many cancers. They improve the outcome...
BackgroundAlthough outcomes of critically ill patients with haematological malignancies (HMs) have been fully investigated in terms of organ failure and mortality, data are scarce on health-related quality of life (HRQOL) in this population. We aim to assess post-intensive care unit (ICU) burden and HRQOL of critically ill patients with HMs and to identify risk factors for...
Neutropenic enterocolitis (NE) is a diagnostic and therapeutic challenge associated with high mortality rates, with controversial opinions on its optimal management. Physicians are usually reluctant to select surgery as the first-choice treatment, concerns being raised regarding the potential risks associated with abdominal surgery during neutropenia. Nevertheless, no published...
Adrie Antoine Gros Michael Darmon Lila Bouadma 0 Jean‑François Timsit jean‑ 0 0 UMR 1137 ‐ IAME Team 5 - DeSCID: Decision Sciences in Infectious Diseases, Control and Care Inserm/Univ Paris Diderot
W. Thille 5 Nicolas Chudeau 12 Julien Huntzinger 11 Steven Grangé 10 Gaetan Beduneau 10 Anne Courte 9 Stephane Ehrmann 14 Jérémie Lemarié 13 Sébastien Gibot 13 Michael Darmon 8 Christophe Guitton 3
Nyunga 10 Fabrice Bruneel 9 Antoine Rabbat 8 Pierre Perez 3 Anne‑Pascale Meert 13 Dominique Benoit 14 Rebecca Hamidfar 11 Michael Darmon 12 Mercé Jourdain Anne Renault Benoît Schlemmer 4 Elie Azoulay 0 4
Albert Raymond, 42270 Saint‐Etienne, Saint‐Priest‐EnJ‐arez , France 1 Jean‐Christophe Richard 2 Jérôme Naudin 3 and Michael Darmon 4 , François Vincent 5 , Jean‐Ralph Zahar 6 , Patricia Ribaud 7
Fartoukh 14 Guillaume Marcotte 9 Laurent Argaud 4 Bruno Verdière 5 Michael Darmon 2 Elie Azoulay 3 Jean‑François Timsit 1 6 7 0 Service de Réanimation et de médecine intensive, Medical‐Surgical ICU, Saint
Asfar Julie Boisramé‑Helms Michael Darmon Jean‑Luc Diehl Jacques Duranteau Eric A. J. Hoste Joannes‑Boyau Olivier Matthieu Legrand Nicolas Lerolle Manu L. N. G. Malbrain Johan Mårtensson Heleen M
Elie Azoulay Marcio Soares Michael Darmon Dominique Benoit Stephen Pastores Bekele Afessa A few decades have passed since intensive care unit (ICU) beds have been available for critically ill
Grants and speaker honorarium from Fresenius: René Robert. Several ongoing research in the field of this recom‑ mendation: Michael Darmon, Frederique Schortgen. Expert designed by Gambro for the European